Over 90 Firms Are Actively Involved In Providing In Silico Services

>

Over 90 firms are actively involved in providing in silico services

Presently, in silico tools / approaches are available for the identification, selection and optimization of pharmacological leads. in fact, the predictive power of such solutions has been demonstrated to enable researchers to bypass the traditional experimental screening of billions of molecules against hundreds of biological targets, thereby, allowing significant reductions in the investment of both time and resources.

 

To order this 290+ page report, which features 120+ figures and 135+ tables, please visit this link

 

The USD 124 million (by 2030) financial opportunity within the in silico drug discovery market for large molecules has been analyzed across the following segments:

  • Key Drug Discovery Steps
  • Target Identification
  • Target Validation
  • Hit Generation
  • Hit-to-Lead
  • Lead Optimization

 

  • Type of Large Molecule
  • Antibodies
  • Proteins
  • Peptides
  • Nucleic Acids
  • Vectors

 

  • Company Size
  • Small
  • Mid-sized
  • Large

 

  • Target therapeutic Area
  • Autoimmune Disorders
  • Blood Disorders
  • Cardiovascular Disorders
  • Gastrointestinal and Digestive Disorders
  • Hormonal Disorders
  • Human Immunodeficiency Virus (HIV) / Acquired Immunodeficiency Syndrome (AIDS)
  • Infectious Diseases
  • Metabolic Disorders
  • Mental Disorders
  • Musculoskeletal Disorders
  • Neurological Disorders
  • Oncological Disorders
  • Respiratory Disorders
  • Skin Disorders
  • Urogenital Disorders
  • Others

 

  • Type of Sponsor
  • Industry Players
  • Non-Industry Players

 

  • Key Geographical Regions
  • North America
  • Europe
  • Asia-Pacific

 

The In Silico / Computer-Aided Drug Discovery Services Market: Focus on Large Molecules, 2020-2030, report features the following companies, which we identified to be key players in this domain:

  • Abzena
  • BioDuro
  • BioNTech
  • ChemPartner
  • Creative Biostructure
  • GenScript
  • LakePharma
  • Sundia MediTech
  • Sygnature Discovery
  • Viva Biotech

 

Table of Contents

 

  1. Preface

    2. Executive Summary

  2. Introduction

  3. Market Landscape

  4. Key Insights

  5. Company Profiles

  6. Company Competitiveness Analysis

  7. Key Opportunity Areas

  8. Emerging Business Models and Strategies

  9. Case study: comparison of drug discovery processes of small molecules and large molecules

  10. Survey insights

  11. Cost saving analysis

  12. Market Forecast

  13. In silico tools and upcoming trends in drug discovery

 

  1. Executive Insights

 

  1. Appendix 1: Tabulated Data

 

  1. Appendix 2: List of Companies and Organizations

 

  1. Appendix 3: Non-Computational Methods for Drug Discovery

 

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/in-silico-drug-discovery/298.html

 

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com

Share:

Keywords: predicts roots analysis

Comments

Other related blogs

The “Prefilled Syringe Fill / Finish Service Providers, 2020-2030” report features an extensive study of the current market

By : Roots Analysis

Key Inclusions A detailed review of the overall landscape of companies offering contract fill / f..


The prefilled syringe fill / finish services market is projected to grow at an annualized rate of over 10%, till 2030

By : Roots Analysis

Roots Analysis has done a detailed study on Prefilled Syringe Fill / Finish Services Market, 2020-20..


The prefilled syringe fill / finish services market is estimated to is estimated to reach close to USD 3 Billion by 2030

By : Roots Analysis

The numerous benefits offered by prefilled syringes, coupled to the growing self-medication trend, h..